drugset / Trial / NCT02794363

Platelet Rich Plasma Injections for Vulvar Lichen Sclerosus

NCT02794363

Completed 15 enrolled Center for Vulvovaginal Disorders
NaSingle-groupOpen-labelTreatment

Summary

15 patients with biopsy proven active vulvar lichen sclerosus will be recruited by a clinic specializing in vulvar disorders. This study consists of a 2 week screening period and a 12-week treatment period. Participants will receive two separate treatments of autologous platelet rich plasma separated by 6 weeks. A repeat biopsy will be performed 6 weeks after the second autologous platelet rich plasma injection

Timeline

Start
2014-05
Primary completion
2016-01
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 5 ml Other